JILL VIDRINE: Open Payments
NPI 1558885160 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,509 in 146 payments from 14 companies in 2025. Trend: 2023 $1,803 · 2024 $2,292 · 2025 $2,509
Food & beverage: $2,425Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $611 |
| Janssen Biotech, Inc. | 25 | $579 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $261 |
| Ardelyx, Inc. | 17 | $226 |
| Madrigal Pharmaceuticals | 14 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $135 |
| QOL Medical, LLC | 6 | $121 |
| Lilly USA, LLC | 7 | $117 |
| GENZYME CORPORATION | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $65 |
Products named: TREMFYA, RINVOQ, XIFAXAN, IBSRELA, REZDIFFRA, LINZESS, ENTYVIO, SKYRIZI.
Industry payments across LA — which companies pay providers there.
